Quarterly report · Q2
6960.TEDINET S100S7MX
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥66.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥134.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥62.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥14.0bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥11.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥14.1bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥25.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.7bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.3bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥210.8bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥206.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥196.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥43.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥171.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥163.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥155.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥70.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥68.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥67.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥63.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥324.32 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.78 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥571.25 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥268.43 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥174.15 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥737m |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.0bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.0bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥66.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥66.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥14.0bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥881m |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)櫻井 紀彰 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梶原 崇宏 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 62628000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 66541000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 134648000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 11662000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 14099000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 25081000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 8119000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 9810000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 17278000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 8401000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 11474000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 18439000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 155139000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 171477000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 163047000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 196864000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 210798000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 206922000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 268.43 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 324.32 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 571.25 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.788 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.813 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.788 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 11287000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 10385000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 23137000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -6526000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -4830000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -14210000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -3104000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -3162000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -5551000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 63421000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 67491000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 64939000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 174.15 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 208.78 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 39176000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 39176000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 39176000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 39176000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |